Skip to content

Characterization & Treatment of Chronic Pain After Moderate to Severe TBI

Characterization & Treatment of Chronic Pain After Moderate to Severe Traumatic Brain Injury

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03739307
Enrollment
3805
Registered
2018-11-13
Start date
2019-05-20
Completion date
2022-10-01
Last updated
2023-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Traumatic Brain Injury

Brief summary

This is a five year multi-site, cross sectional, observational study designed to examine chronic pain and pain treatment after moderate to severe TBI.

Detailed description

The aims of this study are to: 1) Determine chronic pain classification (musculoskeletal, headache, central/neuropathic), prevalence, location, duration, and associations with demographic, injury severity, current level of functioning and comorbidities in participants followed in ten Centers participating in the National Institute on Disability, Independent Living and Rehabilitation Research and the Department of Veterans Affairs TBIMS Databases; 2) Identify extreme groups based on responses to pain (interference and perception of improvement with treatment), or chronic pain extreme phenotypes, in order to define the key differences between those who have a good outcome and those who do not, across factors related to injury, pain severity/location, demographics, and treatment history; and 3) Identify treatment practices by clinicians who treat comorbid TBI and chronic pain to determine gaps in availability/accessibility of guideline level treatment, highlighting underserved populations where applicable. Results from this study will provide a more detailed picture of the problem of chronic pain after TBI by examining the types of pain that occur after TBI, which may be multiple types of pain for a subset of individuals, as well as the frequency of comorbid conditions. Identifying extreme phenotypes, such as demographic, individual, and treatment factors associated with those who have chronic pain but have minimal interference compared to those who are significantly impacted by pain, will allow us to identify treatment targets (behavioral, cognitive, biological, and molecular) to advance a personalized medicine approach to treatment unlike any approach in TBI and chronic pain to date. Outcomes from this study will include educational materials on chronic pain and pain treatment to benefit patients, family members, clinicians, and policymakers. Data from this study will have a direct impact on clinical practice, informing future work, and promoting understanding of constituent factors in extreme phenotypes.

Interventions

None listed

Sponsors

University of Washington
CollaboratorOTHER
James A. Haley Veterans Administration Hospital
CollaboratorFED
Rehabilitation Hospital of Indiana
CollaboratorOTHER
Spaulding Rehabilitation Hospital
CollaboratorOTHER
Wayne State University
CollaboratorOTHER
Mayo Clinic
CollaboratorOTHER
Baylor Institute for Rehabilitation
CollaboratorOTHER
Virginia Commonwealth University
CollaboratorOTHER
NYU Langone Health
CollaboratorOTHER
University of Alabama at Birmingham
CollaboratorOTHER
Moss Rehabilitation Research Institute
CollaboratorOTHER
TIRR Memorial Hermann
CollaboratorOTHER
Craig Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Participants must be enrolled in the TBI Model Systems National Database (TBNIMS NDB) at one of the collaborating sites and thus will meet the TBIMS NDB criteria which are: (1) medical documentation of TBI caused by external mechanical force with either loss of consciousness exceeding 30 minutes, post-traumatic amnesia lasting more than 24 hours, Glasgow Coma Scale score in ER of less than 13, or trauma related intracranial abnormality or neuroimaging abnormalities; (2) admitted to the TBI inpatient rehab program at study sites; and (3) minimum age of 16 \[18 for VA site\]

Exclusion criteria

* Participants unable to participate in the surveys themselves will not be included (i.e. no proxy surveys).

Design outcomes

Primary

MeasureTime frameDescription
Brief Pain Inventory (BPI)Each participant will complete assessment one time during 4 years of data collectionThe BPI will be used to determine pain intensity as well as interference related to pain. Intensity of pain is rated by participant on a scale of 0 (no pain) to 10 (pain as bad as you can imagine) when the pain is at it's worst, least, average, and right now. Pain interference is assessed with seven items using a numeric rating scale ranging from 0 (no interference) to 10 (complete interference). Participants are asked to rate how much pain has interfered with general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life
painDetect QuestionnaireEach participant will complete assessment one time during 4 years of data collectionThis self report survey consists of seven questions about location and quality of neuropathic pain. Scores range from 0-38 with scores above 18 indicating neuropathic pain and higher scores indicating more severity of pain.

Secondary

MeasureTime frameDescription
Post-Traumatic Stress Disorder Checklist-5 (PCL-5)Each participant will complete assessment one time during 4 years of data collectionThe PCL-5 is a 20-item, self-rating scale that provides a quick and accurate measure of PTSD symptoms. Responses are scored on Likert scale (0 = Not at All to 4 = Extremely). Total score of 0 to 80 with higher scores indicating more PTSD symptomatology
Pain Self Efficacy Questionnaire-2 (PSEQ-2)Each participant will complete assessment one time during 4 years of data collectionPSEQ-2 is designed to assess the level of confidence the respondent has in their ability to accomplish daily activities despite their pain. items are rated on a 7-point scale (0 = not at all confident to 6 = completely confident).
Coping Strategies Questionnaire (CSQ)Each participant will complete assessment one time during 4 years of data collectionAn abbreviated version of the CSQ will be used to reduce patient burden. This version uses only two items per domain to assess four coping strategies associated with adjustment to chronic pain: catastrophizing, ignoring pain sensations, increasing behavior, and using coping self-statements. Each item is scored from 0 to 6, with 0 representing 'no use' and 6 representing 'regular use' of the coping strategy. Scores for each domain are the mean score of the two items in that domain.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026